2020 ASA立场声明:阻塞性睡眠呼吸暂停的手术治疗

2020-11-15 澳大拉西亚睡眠协会 Respirology . 2020 Nov 15.

2020年11月,澳大拉西亚睡眠协会(ASA)发布了阻塞性睡眠呼吸暂停的手术治疗的立场声明。手术治疗阻塞性睡眠呼吸暂停的手术治疗(OSA)在当代OSA的治疗中起着重要的作用,是常见的二线治疗手段。本文

中文标题:

2020 ASA立场声明:阻塞性睡眠呼吸暂停的手术治疗

英文标题:

Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association

发布机构:

澳大拉西亚睡眠协会

发布日期:

2020-11-15

简要介绍:

2020年11月,澳大拉西亚睡眠协会(ASA)发布了阻塞性睡眠呼吸暂停的手术治疗的立场声明。手术治疗阻塞性睡眠呼吸暂停的手术治疗(OSA)在当代OSA的治疗中起着重要的作用,是常见的二线治疗手段。本文主要针对OSA的手术治疗提供声明意见。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2020 ASA立场声明:阻塞性睡眠呼吸暂停的手术治疗.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cb7ad1c0020153aa, title=2020 ASA立场声明:阻塞性睡眠呼吸暂停的手术治疗, enTitle=Surgical management of obstructive sleep apnoea: A position statement of the Australasian Sleep Association, guiderFrom=Respirology . 2020 Nov 15., authorId=0, author=, summary=2020年11月,澳大拉西亚睡眠协会(ASA)发布了阻塞性睡眠呼吸暂停的手术治疗的立场声明。手术治疗阻塞性睡眠呼吸暂停的手术治疗(OSA)在当代OSA的治疗中起着重要的作用,是常见的二线治疗手段。本文, cover=https://img.medsci.cn/20201129/1606663568302_2020535.jpg, journalId=0, articlesId=null, associationId=1475, associationName=澳大拉西亚睡眠协会, associationIntro=, copyright=0, guiderPublishedTime=Sun Nov 15 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年11月,澳大拉西亚睡眠协会(ASA)发布了阻塞性睡眠呼吸暂停的手术治疗的立场声明。手术治疗阻塞性睡眠呼吸暂停的手术治疗(OSA)在当代OSA的治疗中起着重要的作用,是常见的二线治疗手段。本文主要针对OSA的手术治疗提供声明意见。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=3180, tagName=阻塞性睡眠呼吸暂停)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=30, categoryName=耳鼻咽喉科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=3180, guiderKeyword=阻塞性睡眠呼吸暂停, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5294, appHits=230, showAppHits=0, pcHits=467, showPcHits=5064, likes=2, shares=10, comments=23, approvalStatus=1, publishedTime=Sun Nov 29 23:34:50 CST 2020, publishedTimeString=2020-11-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Sun Nov 29 23:26:18 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 18:54:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ASA立场声明:阻塞性睡眠呼吸暂停的手术治疗.pdf)])
2020 ASA立场声明:阻塞性睡眠呼吸暂停的手术治疗.pdf
下载请点击:
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1189880, encodeId=8d661189880d6, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL4R6hN3U4rTnAXyZK6M4kvN9xgkwhkTlx2A8alPB0kjcicmFQL48XOdCic7vTEFJRQyDOzbR7RYq5Q/132, createdBy=0ba25167185, createdName=竹子0822, createdTime=Thu Feb 03 12:05:04 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085169, encodeId=f5991085169d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Tue Dec 28 18:28:59 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011315, encodeId=a8c9101131583, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Aug 25 12:35:52 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968291, encodeId=cb4d968291bb, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Tue May 25 00:23:42 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955655, encodeId=a26f9556556a, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=4LU0rbt63k6DJTIfdYc60Q&s=100&t=1580394816, createdBy=8d0c5272401, createdName=哥德巴赫, createdTime=Sat Apr 10 11:07:32 CST 2021, time=2021-04-10, status=1, ipAttribution=)]
    2022-02-03 竹子0822

    学习下

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1189880, encodeId=8d661189880d6, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL4R6hN3U4rTnAXyZK6M4kvN9xgkwhkTlx2A8alPB0kjcicmFQL48XOdCic7vTEFJRQyDOzbR7RYq5Q/132, createdBy=0ba25167185, createdName=竹子0822, createdTime=Thu Feb 03 12:05:04 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085169, encodeId=f5991085169d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Tue Dec 28 18:28:59 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011315, encodeId=a8c9101131583, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Aug 25 12:35:52 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968291, encodeId=cb4d968291bb, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Tue May 25 00:23:42 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955655, encodeId=a26f9556556a, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=4LU0rbt63k6DJTIfdYc60Q&s=100&t=1580394816, createdBy=8d0c5272401, createdName=哥德巴赫, createdTime=Sat Apr 10 11:07:32 CST 2021, time=2021-04-10, status=1, ipAttribution=)]
    2021-12-28 ms5000000018187740

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1189880, encodeId=8d661189880d6, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL4R6hN3U4rTnAXyZK6M4kvN9xgkwhkTlx2A8alPB0kjcicmFQL48XOdCic7vTEFJRQyDOzbR7RYq5Q/132, createdBy=0ba25167185, createdName=竹子0822, createdTime=Thu Feb 03 12:05:04 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085169, encodeId=f5991085169d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Tue Dec 28 18:28:59 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011315, encodeId=a8c9101131583, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Aug 25 12:35:52 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968291, encodeId=cb4d968291bb, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Tue May 25 00:23:42 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955655, encodeId=a26f9556556a, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=4LU0rbt63k6DJTIfdYc60Q&s=100&t=1580394816, createdBy=8d0c5272401, createdName=哥德巴赫, createdTime=Sat Apr 10 11:07:32 CST 2021, time=2021-04-10, status=1, ipAttribution=)]
    2021-08-25 ms5000001266883663

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1189880, encodeId=8d661189880d6, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL4R6hN3U4rTnAXyZK6M4kvN9xgkwhkTlx2A8alPB0kjcicmFQL48XOdCic7vTEFJRQyDOzbR7RYq5Q/132, createdBy=0ba25167185, createdName=竹子0822, createdTime=Thu Feb 03 12:05:04 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085169, encodeId=f5991085169d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Tue Dec 28 18:28:59 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011315, encodeId=a8c9101131583, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Aug 25 12:35:52 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968291, encodeId=cb4d968291bb, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Tue May 25 00:23:42 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955655, encodeId=a26f9556556a, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=4LU0rbt63k6DJTIfdYc60Q&s=100&t=1580394816, createdBy=8d0c5272401, createdName=哥德巴赫, createdTime=Sat Apr 10 11:07:32 CST 2021, time=2021-04-10, status=1, ipAttribution=)]
    2021-05-25

    写的很好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1189880, encodeId=8d661189880d6, content=学习下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTL4R6hN3U4rTnAXyZK6M4kvN9xgkwhkTlx2A8alPB0kjcicmFQL48XOdCic7vTEFJRQyDOzbR7RYq5Q/132, createdBy=0ba25167185, createdName=竹子0822, createdTime=Thu Feb 03 12:05:04 CST 2022, time=2022-02-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1085169, encodeId=f5991085169d2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=184a5613511, createdName=ms5000000018187740, createdTime=Tue Dec 28 18:28:59 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1011315, encodeId=a8c9101131583, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbc45433548, createdName=ms5000001266883663, createdTime=Wed Aug 25 12:35:52 CST 2021, time=2021-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968291, encodeId=cb4d968291bb, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210130/f777d0b91a25425ba588babbf050d6d1/328b4c90fd7741d090ece3b8f155fc70.jpg, createdBy=25525455713, createdName=牛, createdTime=Tue May 25 00:23:42 CST 2021, time=2021-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=955655, encodeId=a26f9556556a, content=写的很好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=4LU0rbt63k6DJTIfdYc60Q&s=100&t=1580394816, createdBy=8d0c5272401, createdName=哥德巴赫, createdTime=Sat Apr 10 11:07:32 CST 2021, time=2021-04-10, status=1, ipAttribution=)]
    2021-04-10 哥德巴赫

    写的很好

    0

拓展阅读

2010 阻塞性睡眠呼吸暂停与糖尿病专家共识

中华医学会呼吸病学分会 · 2010-05-01

2012 AAP儿童阻塞性睡眠呼吸暂停综合征的诊断与治疗指南

美国儿科学会(AAP,American Academy of Pediatrics) · 2012-08-27

2012 SAMBA共识:成人阻塞性睡眠呼吸暂停患者接受门诊手术的术前选择

门诊麻醉学会(SAMBA,The Society for Ambulatory Anesthesia) · 2012-11-01

2013 ERS/ESH 阻塞性睡眠呼吸暂停与高血压患者管理建议

欧洲呼吸学会(ERS,European Respiratory Society) · 2013-05-01